14
Preliminary Program Psychodynamic Psychiatry/ Psychoanalysis: Advances and Innovations May 16 – May 18, 2019 The Westin St. Francis San Francisco on Union Square 335 Powell Street San Francisco, California Registration is open to all mental health professionals and behavioral/social scientists. A Forum for Psychodynamic Psychiatry and Psychoanalysis 63rd Annual Meeting

Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

Preliminary Program

Psychodynamic Psychiatry/Psychoanalysis: Advances

and Innovations

May 16 – May 18, 2019

The Westin St. Francis San Franciscoon Union Square335 Powell Street

San Francisco, California

Registration is open to all mental healthprofessionals and behavioral/social scientists.

A Forum for Psychodynamic Psychiatry and Psychoanalysis

63rd Annual Meeting

Page 2: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

AMERICAN ACADEMY OF PSYCHODYNAMIC PSYCHIATRY AND PSYCHOANALYSIS

OfficersPresident: Gerald P. Perman, MD

President-Elect: Joanna E. Chambers, MDSecretary: Scott C. Schwartz, MDTreasurer: Abby I. Altman, MD

TrusteesMary Ann Cohen, MD

Angela M. Hegarty, MB BChAlicia D. McGill, MDDavid L. Mintz, MDAutumn Ning, MD

Sarah C. Noble, DOJoseph R. Silvio, MDJeffery S. Smith, MDAllan Tasman, MD

Psychodynamic PsychiatryRichard C. Friedman, MD, Editor

César A. Alfonso, MD, Deputy EditorJennifer I. Downey, MD, Deputy Editor

Academy ForumGerald P. Perman, MD, Interim Editor

Academy e-NewsletterAlicia D. McGill, MD, Editor

Executive Director

Jacquelyn T. Coleman, CAE

Executive AssistantMarie L. Westlake

Editorial AssistantSara L. Elsden

Academy Executive Office

One Regency DrivePost Office Box 30

Bloomfield, CT 06002Phone: 888-691-8281

Fax: 860-286-0787Email: [email protected]

Website: www.AAPDPP.org

The Academy is where psychodynamic psychiatrists and physician psychoanalysts: discover a forum for exchange of ideas; find a voice within the American Psychiatric Association (APA) to advocate for

psychodynamic understanding in the evaluation and treatment of patients; take a leadership role in promoting the importance of psychodynamic

training in residency and medical education.

The American Academy of Psychodynamic Psychiatry and Psychoanalysis (AAPDPP) is an affiliate organization of the World Psychiatric Association

(WPA) and the American Psychiatric Association (APA).

Page 3: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

American Academy of Psychodynamic Psychiatry and Psychoanalysis

63rd Annual Meeting

Psychodynamic Psychiatry/Psychoanalysis:Advances and Innovations

May 16 – May 18, 2019

The Westin St. Francis San Francisco on Union Square335 Powell Street

San Francisco, California 94102

Program Co-Chairs:Alicia D. McGill, MDSilvia W. Olarte, MD

Chair of the Scientific Program Committee:Joseph R. Silvio, MD

CME Committee Chair:Silvia W. Olarte MD

Message from the Program Co-Chairs: The founding members of the Academy were committed to developing an association that would provide a forum for the free expression of ideas and the advancement of concepts and research in Psychoanalysis. By 1996 the Academy recognized the expanded scope of its membership and added “Psychodynamic Psychiatry” to its name. By 2013, Academy journal editors were ready to define Psychodynamic Psychiatry as, ”a new discipline that has emerged from a fusion of psychoanalytic and extra-psychoanalytic psychology, neuroscience, and academic psychiatry” (Psychodynamic Psychiatry 41(4) 511-512 2013). This was followed by a change in the organization’s name to The American Academy of Psychodynamic Psychiatry and Psychoanalysis (AAPDPP). This change reflects the shift in training and practice of contemporary psychiatrists and the Academy’s efforts to provide a welcoming forum for new and innovative ideas in these augmented fields.

Since the expansion of our name and purpose, our annual meetings have been designed to explore how Psychoanalysis and Psychodynamic Psychiatry foster the evolution and integration of these disciplines into the ever-changing specialty of Psychiatry. The basis for our inquiries lies in the psychoanalytic theories that established concepts, processes, and the descriptive language we use. From this foundation, case studies and selections of clinical experiences can be used to illustrate and enrich the understanding of theoretical concepts. Indeed psychoanalytic interpretations have long since migrated from the consulting room to influence various areas of academic pursuit, including psychoanalysis applied to the arts, literature and biographical inquiries. Explicitly and implicitly, dynamic theories have spawned and influenced allied fields including various approaches to psychotherapy based on social science and neuroscience research.

This year’s meeting seeks to provide members with a status report on existing efforts to elaborate upon psychoanalytic and psychodynamic thinking. These efforts are resulting in the development of re-imagined theoretical concepts and the application of new, derivative clinical techniques. The content of this year’s meeting will also provide methods for interrogating our foundational psychoanalytic concepts with the tools supplied by neurobiological science and multicultural insights. Indeed the direction for our future collective work will also be open for discussion and given helpful frameworks by those who are training the next generation of clinicians and researchers and by those who are daily seeking to address the particular demands of modern clinical settings.

Page 4: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

Program: The disciplines of Psychoanalysis and Psychodynamic Psychiatry are both rooted in the essence of clinical processes such as the exploration of past experience and their connection to the present, the fundamental role of the unconscious in understanding motivation, the use of transference and counter-transference phenomena and the role of the therapeutic relationship among others.

A number of presenters will share their experiences with utilizing psychoanalytic and psychodynamic tenets to better treat challenging patients in a variety of settings. Presenters will report on their work including the use of art therapy in underserved neighborhood clinics, outreach services that seek to train providers and parents in infant mental health and the efforts of those who seek to thoughtfully modify treatment frames to accommodate incapacitating physical illness. Presenters will also consider the ways in which cultural differences between patient and therapist introduce challenges to the therapeutic relationship or allow for transcendence of divides based on similarities and emphasized shared humanity.

We will hear from colleagues who are thinking about contemporary cultural issues such as depression in children of the affluent, non-binary gender identity and adaptations to CL psychiatry in the realm of “patient-centered care” such that unconscious factors can be rightfully considered. Not surprisingly, psychodynamic psychiatry continues to influence the work of clinicians well beyond the United States. Colleagues from Southeast Asia will inform us about their work in various psychiatric settings and European colleagues will consider the impact of changing epidemiology on the efficacy of long-term psychotherapy treatments.

The Academy’s longstanding commitment to inclusivity in the realm of psychoanalytic theory invites the contributions of presenters who seek to share their preferred theoretical perspective as well as their attempts to advance theoretical concepts. To this end we will be treated to presentations on dream interpretation from various psychoanalytic schools of thought. A presenter with first-person experience of the Second Chechen War will lead us to consider psychoanalytic explications for the motivation behind modern day acts of terrorism. Some theorists among us will return to Freud’s original work and wonder about whether or not Freudian theories can be seen as supported by science or if advances in our understanding of early development requires a complete re-conceptualization of Freudian theory. Still others will encourage us to revisit primary psychoanalytic tenets to create treatment frames that best support efforts towards effective treatment of severe character pathology.

Neuroscience findings command an ever-growing influence on psychiatry with advancing identifications of neural networks that seemingly underlie and correspond with manifestations of human emotion, motivation and behavior. Various presenters will invite us to consider ways in which patients treated in psychodynamic psychiatry can be additionally helped when provided with experience-near explanations of the brain-based mechanisms undergirding their struggles with self-defeating compulsions such as addiction and neurotic repetitions of maladaptive behavior.

Presenters will provide case studies to reflect their forays into the use of brain-based interpretation. Additionally a psychobiography of Tennessee Williams will seek to further these endeavors given what we know of the reported limitations of psychoanalytic treatment to address the playwright’s various compulsions and experience with unremitting depression. Contributions from neuroscience will also be used to consider various “talk therapies”, including psychodynamic psychiatry, and the likely neurological basis for therapeutic action across psychotherapies.

Page 5: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

Indeed some presenters will seek to convince us that discovery in neuroscience, and the data collection and related algorithms created, will ultimately serve to validate psychodynamic approaches to treatment. Still others will encourage us to wonder about what may be lost or obscured in the current efforts to “fuse” or bridge the gaps between the findings of neuroscience and the subtleties and elusory aspects of what transpires during psychodynamic and psychoanalytic treatments. Finally, we will be invited to consider particular elements of the human experience that play crucial roles in the reparative, therapeutic experience but have yet to be fully elucidated by neuroscience including resilience and creativity.

Neurobiology has contributed a great deal to our understanding of the role for medications in the alleviation of psychic suffering but as psychoanalytic and psychodynamic informed therapists, we also grapple with the best practice methods for prescribing medications within an ongoing psychotherapeutic treatment. A peer psychopharmacology session during the meetings will create an opportunity to consider relevant, challenging issues. Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists and consider ways in which the subjective experiences generated by the use of these medicines may serve to support the aims of insight-oriented therapies.

Importantly, we will be called upon to consider the future direction for the training and supervision of psychiatry residents in programs across the country. Indeed residency programs are under pressure to prepare psychiatric residents to function well in a variety of settings that increasingly privilege medication management and collaborative care. We will be invited to listen to the first hand experiences of recent psychiatric residents and to contemplate the arguments for the renewed importance of psychodynamic psychiatry in the training of tomorrow’s leaders in the field of general psychiatry.

The Academy is not only concerned with the patients we treat but also the mental health of those providing treatment. To that end, the Academy has enlisted a group of its most creative and committed members to explore ways in which the Academy could offer support to its members. Our Opening Session entitled, How Can Psychiatric Associations Offer Support to Their Members, will be given by Dr. Douglas Ingram.

It is the good fortune of the Academy to count among its members a group of outstanding professionals who have committed their professional careers to work in a long term care facility dedicated to psychodynamic psychiatry and psychoanalysis. Our disciplines and the work of those at Austen Riggs have evolved over time. Drs. David Mintz and Eric Plakun, accompanied by other members of the Austen Riggs group, will provide the Keynote Address entitled, How to Evolve and Be True to the Principles. They will share with us their thoughtful approach to the challenging experience of serving a unique patient population in a long-term residential setting which has become the exception rather than the norm for psychiatric care.

Drs. Eugenio Rothe and Fructoso Irigoyen will offer the first Plenary Session. This inventive talk will helpfully revisit the story of Don Quixote through the lens of psychodynamic thinking. The second Plenary Session will be provided by Drs. Gerald Perman and Douglas Ingram. Dr. Perman will expertly provide participants with an introduction to the theoretical work of Jacques Lacan. Dr. Perman, with Dr. Ingram as the discussant, will then build on this topic by sharing suggestions for how challenging Lacanian concepts can be applied to our clinical practices.

Page 6: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

Finally, Dr. Richard Friedman will deliver the meeting’s Presidential Address. The title of Dr. Friedman’s talk will be Modern Psychodynamic Psychiatry. As the Editor of the AAPDPP journal, “Psychodynamic Psychiatry”, Dr. Friedman has made substantial contributions to our understanding of what constitutes psychodynamic psychiatry.

The American Academy of Psychodynamic Psychiatry and Psychoanalysis is an affiliate organization of the American Psychiatric Association and World Psychiatric Association.

Conference Learning Objectives: This meeting has been designed to meet the following professional practice gaps and the needs derived from those gaps:

Gap #1:Improving treatment of patients by:A. Attaining sufficient knowledge of psychodynamic principles

and the ability to apply this knowledge.B. Enhancing the ability to integrate dynamic principles,

psychopharmacology, and neuroscience in clinical practice. Needs derived from the gaps above:

A. To learn about development of therapeutic alliances; transference and countertransference; the handling of challenging situations; and practical applications of psychoanalytic theories.

B. To learn about complex pathologies, neuroscientific advances, pharmacological treatments, and medical conditions and their implications/ramifications for psychodynamic psychotherapy.

Gap #2:Enhancing training of residents and early career psychiatrists.Needs derived from this gap:A. To learn new ways of engaging residents and training them

in the complex theories and techniques of psychodynamic psychotherapy.

B. To foster learning of complex theories and techniques of psychodynamic psychotherapy by early career psychiatrists.

All presentations must address at least one of the specified needs.

The Academy expects the results of its CME program to be an improvement in competence or performance. Definitions: “Competence” refers to knowing how to do something; and “Performance” is what a psychiatrist would do in practice if given the opportunity.

Target Audience: Those interested in the recent developments and clinical application of psychodynamic approaches: a) psychoanalysts, psychiatrists, child and adolescent psychiatrists, other physicians, residents and fellows; b) psychologists, interns and students of psychology; c) social workers, students of social work; d) allied professionals and students.

The American Academy of Psychoanalysis and Dynamic Psychiatry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Psychoanalysis and Dynamic Psychiatry designates this live activity for a maximum of 24.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Academy of Psychoanalysis and Dynamic Psychiatry acknowledges the generous support of the Alexandra and Martin Symonds Foundation to its educational programs.

Page 7: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

THURSDAY, MAY 16, 2019

7:00 PMREGISTRATION

7:30 PM - 9:00 PMOPENING SESSION

Welcome: Alicia D. McGill, MD (New York, NY) IntroductoryRemarks: Silvia W. Olarte, MD (New York, NY)

Chair andModerator: Douglas H. Ingram, MD (New York, NY)

Presentation: HOW CAN PSYCHIATRIC ASSOCIATIONS OFFER SUPPORT TO THEIR MEMBERS?

Presenters: Kimberly R. Best, MD (Philadelphia, PA) Norman A. Clemens, MD (Chagrin Falls, OH) Mariam C. Cohen MD PsyD PhD (Scottsdale, AZ) Debra A. Katz, MD (Lexington, KY) Eugenio M. Rothe, MD (Key Biscayne, FL) Scott C. Schwartz, MD (New York, NY) John S. Tamerin, MD (Greenwich, CT)

9:00 PM – 10:00 PMOPENING NIGHT RECEPTION (cash bar)

FRIDAY, MAY 17, 2019ROOM A - MORNING SESSION8:00 AM – 8:55 AMPANEL: THE EMERGENCE OF THE MIND AT BIRTH: DEATH INSTINCT AND KNOWLEDGE

Chair and Moderator: Joanna E. Chambers, MD (Indianapolis, IN)

Presenters: Daniela Polese, MD (Rome, Italy) Alessandro Mazzetta, MD * (Rome, Italy) Francesca Fagioli, MD * (Rome, Italy)

9:00 AM – 10:55 AMPANEL: ADVANCES IN PSYCHODYNAMIC PSYCHIATRY IN SOUTHEAST ASIA

Chair César Alfonso MD (New York, NY)Discussant: Rizky Aniza Winanda, MD (West Papua, Indonesia)

Presenters: Alma Jimenez MD * (Manila, Philippines) USING A PSYCHODYNAMIC FRAMEWORK IN THE TREATMENT OF PERSONS WITH BORDERLINE PERSONALITY DISORDER WITH SELF-INJURIOUS BEHAVIOR IN THE PHILIPPINES

Rasmon Kalayasiri MD * (Bangkok, Thailand) INTEGRATION OF PSYCHODYNAMIC AND MOTIVATIONAL INTERVIEWING MODELS IN THE TREATMENT OF ADDICTION IN THAILAND

Constantine D. Della MD * Manila, Philippines) PSYCHODYNAMIC PSYCHIATRY IN THE CONSULTATION AND LIAISON GENERAL HOSPITAL SETTING IN THE PHILIPPINES Marco C. Michael MD (New York, NY) CULTURAL AWARENESS TO FACILITATE PSYCHOTHERAPY IN SOUTHEAST ASIAN COUNTRIES

Page 8: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

David Choon Liang Teo, MD (Singapore) PSYCHODYNAMIC PSYCHIATRY IN SINGAPORE - CHALLENGES AND OPPORTUNITIES

11:00 AM – 12:55 PMPAPER SESSION I:Chair: Sarah C. Noble, DO (Philadelphia, PA)

Discussant: Joseph R. Silvio, MD (Bethesda, MD)

Presenters: Autumn Ning, MD (Coral Gables, FL) FLEXING THE FRAME: INCLUSION AND CONNECTION, RECONCILING DISTANCE IN A CASE OF TRAUMA W. Scott Griffies, MD (Raleigh, NC) TENNESSEE WILLIAMS’ EMOTIONAL SUFFERING, INSIGHTS FROM “A REETCAR NAMED DESIRE” AND NEUROPSYCHODYNAMIC CONSIDERATIONS

David L. Lopez, MD (Greenwich, CT) ADOLESCENT GENDER IDENTITY CRISIS: A PSYCHODYNAMIC APPROACH

Jeffery S. Smith, MD (Scarsdale, NY) EFFICIENCY OF TRAINING THROUGH THEORETICAL INTEGRATION

ROOM B - MORNING SESSION8:00 AM – 8:55 AMWORKSHOP: NOT YOUR GRANDMOTHER’S RESIDENCY

Chairand Discussant: Kimberly R. Best MD (Philadelphia, PA)

Presenters: Christopher Nemes MD * (Philadelphia, PA) Dileep Borra MD (Wausau, WI)

9:00 AM – 10:30 AMWORKSHOP: UNSCRIPTING: IMPROVISATIONAL THEATER EXPERIENCES FOR RESIDENT TRAINING IN PSYCHODYNAMIC PSYCHOTHERAPY

Chairand Discussant: Jeffrey Katzman, MD (Albuquerque, NM)

10:35 AM – 12:55 PMPANEL: ONE DREAM, THREE PERSPECTIVES: THE PLACE OF THE DREAM AND DREAMING IN CLINICAL PRACTICE

Chairand Discussant: Norman A. Clemens, MD (Chagrin Falls, OH)

Presenter: Jan Seriff, PhD * (Newton, MA)

Commentators: Adam Goldyne, MD * (San Francisco, CA) Michael D. Levin, PsyD * (San Francisco, CA) Harriet Wolfe, MD * (San Francisco, CA)

1:00 PM – 1:25 PM Lunch Break For those interested to have a “brown bag lunch” (bring your own), a meeting room will be available to meet and network with other similar-minded attendees.

Page 9: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

ROOM A - AFTERNOON SESSION1:30 PM – 2:40 PMPLENARY SESSION: DON QUIXOTE “THE DEVINE MADMAN”: THE PSYCHIATRIC DIMENSIONS OF HIS JOURNEY AND HIS LEGACY

Chairand Discussant: Eugenio M. Rothe, MD (Coral Gables, FL)

Presenter: Fructoso Irigoyen, MD * (McAllen, TX)

2:45 PM – 4:15 PMWORKSHOP: RESIDENTS WORKSHOP: CLINICAL MANAGEMENT OF COUNTERTRANSFERENCE PRACTICAL RECOMMENDATIONS

Co-Chairs: César Alfonso MD (New York, NY) Timothy B. Sullivan MD * (New York, NY)

Presenters: Jennifer Sotsky MD * (New York, NY) Marco C. Michael MD (New York, NY) Vivek Jain MD * (Staten Island, NY) Kseniya Svyatets MD * (Staten Island, NY)

4:20 PM – 5:50 PMPANEL: HEALING THROUGH NEUROSCIENCE

Chair: Mary Ann Cohen, MD (New York, NY)

Discussant: Joseph J. Rasimas, MD, PhD (Minneapolis, MN)

Presenters: Elizabeth A. Greene, MD (Belvoir, VA) Shran D0. Shukla MD * (Belvoir, VA) Ioana M. Horotan MD * (Belvoir, VA)

ROOM B - AFTERNOON SESSION 2:45 PM – 4:15 PMPANEL: PSYCHOTHERAPY FROM DIFFERENT PERSPECTIVES

Chair: Damian D. Kim MD (Brooklyn, NY)

Discussant: Richard C. Friedman MD (New York, NY)

Presenters: CAUSALITY-BASED PSYCHOTHERAPY: INVISIBLE MIND MATTERS Damian D. Kim MD (Brooklyn, NY)

NO-SELF BASED PSYCHOTHERAPY: WE CANNOT CONTROL OUR MIND AND BODY Hyunsoo Jeon MD PhD * (Seoul, Korea) SELF-ANALYSIS OF PSYCHOTHERAPISTS BY SATI PRACTICE (MINDFULNESS): BUILD BETTER THERAPEUTIC ALLIANCE Yonghan Park MD * (Jejudo, Korea)

4:20 PM – 5:50 PMWORKSHOP: THERAPEUTIC IMPASSE: HOW TO RECOGNIZE IT, HOW TO RESOLVE IT – CLINICAL VIGNETTES

Chair: Scott C. Schwartz MD (New York, NY)

Discussants: Douglas H. Ingram, MD (New York, NY) Silvia W. Olarte, MD (New York, NY)

Presenters: Monika Gashi, MD (New York, NY) Alejandra Cattan, MD * (New York, NY) Alaa Elnajjar, MD * (New York, NY)

Page 10: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

ROOM A - AFTERNOON SESSION6:00 PM – 7:30 PMKEYNOTE HOW TO EVOLVE AND BE TRUE TO THEADDRESS PRINCIPLES

Chair: Alicia D. McGill, MD (New York, NY)

Presenters: David L. Mintz, MD (Stockbridge, MA) Eric M. Plakun, MD (Stockbridge, MA)

SATURDAY, MAY 18, 2019ROOM A - MORNING SESSION8:00 AM – 9:55 AMWORKSHOP: PSYCHOPHARMACOLOGY IN PRACTICE

Co-Chairs: Joseph R. Silvio, MD (Bethesda, MD) Juan Raul Condemarin, MD (Boston, MD)

Presenter: GLUTAMATE-NMDA RECEPTORS: CLINICAL IMPLICATIONS Juan Raul Condemarin MD (Boston, MA)

10:00 AM – 11:55 AMPAPER SESSION II:

Chair: Asher Aladjem, MD (Paterson, NJ)

Discussant: Sherry Katz-Bearnot, MD (New York, NY)

Presenters: CONTINUING TO DISTURB THE SLEEP OF MANKIND: ADVANCES IN PSYCHOANALYTIC TREATMENTS AND THE IMPORTANCE OF UNDERSTANDING THEIR ADVERSARIES Joanne M. Emmens, MS * Auckland, New Zealand)

ALGORITHM OF UNCONSCIOUS DRIVERS OF PATIENT-PROVIDER THERAPEUTIC RELATIONSHIP Clifford Gimenez, MD (Thousand Oaks, CA)

LONG TERM INDIVIDUAL PSYCHOANALYSIS: DO WE STILL NEED IT FOR THERAPY? Reimer Hinrichs, MD (Berlin, Germany)

THE SHAME OF EDEN: WHY PSYCHOTHERAPEUTIC GROUND RULES MATTER MOST FOR OUR SICKEST PATIENTS Benjamin S.P. Israel, MD (Baltimore, MD)

12:00 PM – 12:55 PMWORKSHOP: IT’S NEVER TOO LATE: NOVEL THERAPEUTIC TECHNIQUES WITH AT-RISK TEENS AND PRESCHOOLERS FROM THE CARING AT COLUMBIA PROGRAM

Chair: Clarice J. Kestenbaum MD (New York, NY)

Presenters: Ebony Renae Davis MD (Lake Fort Worth, FL) Laura Gonzalez Conty MD (New York, NY)

ROOM B - MORNING SESSION8:00 AM – 8:40 AMWORKSHOP: PSYCHEDELICS REVISITED

Chairand Discussant: Gregory C. Mahr, MD (Northville, MI)

Presenter: Jamie Sweigart MD * (Van Buren Township, MI)

Page 11: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

8:45 AM – 10:15 AMPAPER SESSION III:

Chair: Abby I. Altman, MD (New York, NY)

Discussant: Jennifer I. Downey, MD (New York, NY)

Presenters: THE ORIGINS OF TERRORISM Nina E. Cerfolio, MD (New York, NY) THE IMPACT OF CULTURE ASSOCIATIONS IN THE THERAPEUTIC ALLIANCE Helen Ullrich MD PhD (New Orleans, LA) DEPRESSION IN THE MIDST OF AFFLUENCE John S. Tamerin, MD (Greenwich, CT)

10:20 AM – 11:25 AMPANEL: ON RESILIENCE IN PSYCHODYNAMIC PSYCHIATRY

Chair: Ahron L. Friedberg MD (New York, NY)

Presenters: Vladan Novakovic MD * (New York, NY) Nathan Szajnberg MD * (Palo Alto, CA)

11:30 AM –12:55 PMSYMPOSIUM: PSYCHOANALYSIS AND CREATIVITY IN THE ERA OF BIG DATA AND NEUROSCIENCE

Chair: Hervé Granier MD * (Montpellier France)

Discussant: César Alfonso MD (New York, NY)

Presenters: CREATIVITY IN PSYCHOANALYSIS AND ITS NEUROPSYCHOLOGICAL EFFECT Maria Ammon MD * (Berlin, Germany)

BIG DATA AND PERSON-CENTERED MEDICINE INTEGRATIVE DIAGNOSTICS Michel Botbol MD * (Bohars, France)

WHAT IS PSYCHOANALYSIS IN THE ERA OF NEUROSCIENCE? Hachem Tyal MD * (Casablanca, Morocco)

Albrecht Göring, PhD (Munich, Germany) EVOLVING CONCEPTS OF ANDROGYNY AND GENDER STEREOTYPES

1:00 PM -1:25 PM Lunch Break For those interested to have a “brown bag lunch” (bring your own), a meeting room will be available to meet and network with other similar-minded attendees.

ROOM A - AFTERNOON SESSION1:30 PM – 2:40 PMPLENARY SESSION: JACQUES LACAN: AN INTRODUCTION TO HIS WORK WITH APPLICATIONS FOR YOUR PRACTICE

Chair andDiscussant: Douglas H. Ingram, MD (New York, NY)

Presenter: Gerald P. Perman, MD (Washington, DC)

2:45 PM – 4:15 PMPANEL: INSIGHTS FROM INFANT MENTAL HEALTH FOR THE PRACTICING PSYCHOTHERAPIUST?

Chair: Alexandra M. Harrison MD (Cambridge, MA)

Discussant: David L. Lopez, MD (Greenwich, CT)

Page 12: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

Presenters: Abishek Bala MD * (Saginaw, MI) Henry Rafael Marquez MD (Houston, TX) Muhammad Zeshan MD (Malden,MA) Alayne Stieglitz MD (San Francisco, CA)

4:15 PM – 5:40 PMSYMPOSIUM: WHAT’S HAPPENING TO TRAINING IN PSYCHODYNAMIC PSYCHIATRY AND WHAT CAN WE DO ABOUT IT?

Chair: Jeffrey Katzman, MD (Albuquerque, NM)Discussant: Jeffrey Tuttle, MD (Lexington, KY)

Presenters: DEVELOPMENT OF A PSYCHODYNAMIC TRAINING CURRICULUM Jeffrey Katzman, MD (Albuquerque, NM)

INTRODUCING A DIALOGIC APPROACH TO WORKING WITH FAMILIES IN AN EARLY PSYCHOSIS CLINIC Rochelle Lenroot MD * (Albuquerque, NM)

PSYCHODYNAMIC PSYCHOTHERAPY IN A TREATMENT REFRACTORY MOOD DISORDERS OUTPATIENT CLINIC Lucas Dunklee MD * (Albuquerque, NM)

PSYCHODYNAMIC PSYTHOTHERAPY ON AN INPATIENT UNIT Hammam Yahya MD * (Albuquerque, NM)

ROOM B - AFTERNOON SESSION2:45 PM – 3:40 PM WORKSHOP: PSYCHOANALYSIS AND NEUROSCIENCE

Chairand Discussant: Joanna E. Chambers, MD (Indianapolis, IN)

Presenter: Richard M. Brockman, MD (New York, NY)

3:45 PM – 5:40 PMSYMPOSIUM: BRIDGING THE GAP BETWEEN PSYCHOANALYSIS AND NEUROSCIENCE

Chair: Michel Botbol MD * (Bohars, France)

Discussant: Maria Ammon MD * (Berlin, Germany)

Presenters: BRIDGING THE GAP BETWEEN THE SUFFERING MIND AND THE DYSFUNCTIONAL BRAIN Fabian Guenole MD * (Caen, France) ARTIFICIAL INTELLIGENCE AND THE FUTURE OF PSYCHIATRY Mario Eduardo Costa Pereira MD * (Sao Paulo, Brazil)

INDIVIDUAL REPRESSION AND SOCIAL SYMPTOMS Hervé Granier MD (Montpellier, France)

5:45 PM – 6:45 PM ANNUAL BUSINESS MEETING

ROOM B6:45 PM – 7:45 PMPRESIDENTIAL ADDRESS AND AWARDS:

MODERN PSYCHODYNAMIC PSYCHIATRY

Introduction: Gerald P. Perman, MD (Washington, DC)

Presenter: Richard C. Friedman, MD (New York, NY)

7:45 PM – 9:00 PMATTENDEES RECEPTION (cash bar)

* Invited Speaker

Page 13: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

MEETING REGISTRATION FORMTHE AMERICAN ACADEMY OF PSYCHODYNAMIC PSYCHIATRY

AND PSYCHOANALYSIS63rd Annual Meeting

San Francisco, CaliforniaMay 16 - May 18, 2019

Advance registration is recommended. Badges will be held at the AAPDPP Registration Desk at the hotel.

If you are not an AAPDP member, please tell us how you heard of this meeting: r Referred by a Member r Ad r Website r Mail r Other _________________________________________________________

Please type or print clearly:

Name & Degree ___________________________________________________

Address __________________________________________________________

City, State, Zip_____________________________________________________

Phone _________________________ Fax ____________________________

E-Mail ___________________________________________________________

Professional Specialty ______________________________________________* Guests requiring Continuing Medical Education credits should register as non-member professionals. Advance On-Siter Member of the Academy $350.00 $400.00 r Non-Member Spouse/Accompanying Guest* $110.00 $130.00 Name & Degree __________________________________

r Non-Member Professional* $425.00 $475.00 r Non-Member Spouse/Accompanying Guest* $110.00 $130.00 Name & Degree _______________________________

r Non-Member Speaker $100.00

r Non-Member Speaker Spouse/Accompanying Guest $100.00

r One-Day Registration $155.00 $175.00 Day ________________________________________

r Candidate, Psychoanalytic Institute (Requires current letter from Training Director) $155.00 $175.00

r Resident in Psychiatry or Medical Student (Requires Resident/Medical Student ID) No Charge

r Student (Full time Student ID Required) $155.00 $175.00

Total Registration Amount $_________________

MASTERCARD AND VISA ACCEPTED (please circle one)

Card No. _________________________________________________________

Exp. Date: _____________________ Security Code: _________________

Signature _________________________________________________________

Please complete and return this form with your check (in US dollars and drawn on a US Bank) or credit card information:

AMERICAN ACADEMY OF PSYCHODYNAMIC PSYCHIATRYAND PSYCHOANALYSIS

One Regency Drive, P.O. Box 30, Bloomfield, CT 06002Phone: (888) 691-8281 Fax: (860) 286-0787

Email: [email protected] Website: www.aapdp.org

Page 14: Preliminary ProgramNeurobiology has contributed a great deal to our understanding ... Additionally, presenters will offer various updates on the use of psychedelic drugs and NMDA antagonists

The

Am

eric

an A

cade

my

of P

sych

odyn

amic

Psy

chia

try

and

Psyc

hoan

alys

isO

ne R

egen

cy D

rive

, P.

O.

Box

30

Blo

omfi

eld,

CT

0600

2

PLEA

SE P

OST

PR

OG

RA

M